EM
AGN

Elliott Management’s Allergan plc AGN Stock Holding History

Elliott Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,735,000
Closed -$574M – 89
2016
Q4 		$574M Hold
2,735,000
– – 4.31% 6
2016
Q3 		$630M Hold
2,735,000
– – 5.14% 5
2016
Q2 		$632M Buy
2,735,000
+237,949
+10% +$54.9M 5.43% 5
2016
Q1 		$669M Buy
2,497,051
+476,551
+24% +$136M 7.03% 4
2015
Q4 		$631M Buy
2,020,500
+1,357,500
+205% +$404M 7.64% 4
2015
Q3 		$180M Buy
+663,000
New +$204M 3.45% 8

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Elliott Management's AGN Position: Q1 2017 in Review

Elliott Management sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 2,735,000 shares — an estimated $574M sold.

Elliott Management first reported a position in AGN in Q3 2015 and held it in 6 quarters. The position peaked at $669M in Q1 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Elliott Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Elliott Management sold 2,735,000 Allergan plc shares in Q1 2017, an estimated $574M.
  • Elliott Management first reported a position in Allergan plc in Q3 2015 and held it in 6 quarters.
  • Elliott Management's Allergan plc position peaked at $669M in Q1 2016.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Elliott Management's 13F filing for Q1 2017, filed 15 May 2017.